cGMP-Aligned · FDA-Registered U.S. Facility · Third-Party COA on Every LotSupplied for Research Use Only
Research Use Only

Areas under active research.

MSC-derived exosomes are not FDA-approved for medical treatment and are supplied exclusively for research purposes. Explore the areas researchers are studying.

Orthopedic & jointOsteoarthritisKnee cartilageTendon & ligamentBone fracture healingWound healingDiabetic wound careSkin rejuvenation & anti-agingHair restorationStroke recoveryTraumatic brain injuryAlzheimer’s & Parkinson’sSpinal cord researchMultiple sclerosisPeripheral neuropathyAutismDepression & mental healthCardiac & heartCOPD & lungLiver (NAFLD)Kidney & renalCrohn’s & IBDSjögren’s syndromeDiabetes & metabolicEye & retinalHearing lossMen’s healthSepsis & critical careOncology support

Important Information

These statements have not been evaluated by the U.S. Food and Drug Administration. BioRegenEx products are not intended to diagnose, treat, cure, or prevent any disease.

Exosome therapy is an emerging regenerative approach. It is investigational, outcomes vary, and individual results cannot be guaranteed. Patient testimonials reflect individual experiences and are not representative of typical results.

References to regulatory standards — including Section 351(a) of the Public Health Service Act — describe the company’s stated quality and compliance approach and should not be interpreted as FDA approval or endorsement of any product.

This presentation is provided for educational and informational purposes only and does not constitute medical advice. Treatment decisions should always be made in consultation with a qualified, licensed healthcare provider.